Table 3:

Multivariable analysis for participants with previous cerebrovascular ischemic events^a

	Multivariable
	OR	95% CI	P
Age (yr)	0.99	0.91–1.08	.88
Female	0.43	0.07–2.72	.37
Active smoker	7.50	1.10–51.47	.04
Diabetes mellitus	10.25	0.91–115.92	.06
Hypertension	0.58	0.10–3.34	.54
Hyperlipidemia	0.51	0.08–3.14	.47
Statin use	0.81	0.06–9.84	.87
Aspirin use	0.99	0.10–9.70	.99
Stenosis (%)	0.05	0.02–1.50	.09
Maximum wall thickness (mm)	0.77	0.40–1.45	.42
Adventitial enhancement (category 1 vs category 0)	14.90	0.98–225.93	.05
Adventitial enhancement (category 2 vs category 0)	51.17	3.40–469.80	.004
IPH presence	10.18	1.42–72.21	.02

^aAdjusting for coils and gadolinium dose.